These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4210478)

  • 1. A self control method for long term anticoagulation therapy.
    Erdman S; Vidne B; Levy MJ
    J Cardiovasc Surg (Torino); 1974; 15(4):454-7. PubMed ID: 4210478
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
    Acar J
    J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
    Gohlke-Bärwolf C; Acar J; Burckhardt D; Oakley C; Butchart E; Krayenbühl P; Hall R; Bodnar E; Krzeminska-Pakula M; Delahaye JP
    J Heart Valve Dis; 1993 Jul; 2(4):398-410. PubMed ID: 8269142
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of thromboembolism after hip fracture.
    Lyon LJ; Nevins MA
    Geriatrics; 1973 Jan; 28(1):107-10. PubMed ID: 4566617
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
    Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
    Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems in the care of patients with heart valve prosthesis].
    Kirchner K; Ursinus W; Erbstösser H
    Z Arztl Fortbild (Jena); 1984; 78(3):77-81. PubMed ID: 6426179
    [No Abstract]   [Full Text] [Related]  

  • 8. High complication and failure rates of anticoagulant therapy are unavoidable.
    Nitter-Hauge S; Dale J
    Z Kardiol; 1986; 75 Suppl 2():293-7. PubMed ID: 3727705
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of anticoagulants in preventing embolization from prosthetic heart valves.
    Gadboys HL; Litwak RS; Niemetz J; Wisch N
    JAMA; 1967 Oct; 202(4):282-6. PubMed ID: 6072302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant therapy in vascular surgery for acute obliterations].
    Eide M
    Med Klin; 1971 Nov; 66(46):1578-81. PubMed ID: 5002974
    [No Abstract]   [Full Text] [Related]  

  • 11. High complication and failure rates of anticoagulant therapy are avoidable.
    Broekmans AW; Loeliger EA
    Z Kardiol; 1986; 75 Suppl 2():298-301. PubMed ID: 3727706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of thromboembolism following heart valve replacement].
    van de Loo J; Stenzinger W
    Verh Dtsch Ges Inn Med; 1989; 95():275-82. PubMed ID: 2690497
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of hemorrhagic and thromboembolic complications in heart valve prosthesis].
    Pospelova EP; Stepanian EP; Shchurkalina TKh; Movsesian RA
    Grudn Khir; 1971; 13(1):49-51. PubMed ID: 5577527
    [No Abstract]   [Full Text] [Related]  

  • 14. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 15. [Surgery of the patients on anticoagulants following prosthetic valve replacement].
    Kosuga K; Aoyagi S; Shima H; Yanagi I; Oryoji A; Oishi K; Koga M
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):779-84. PubMed ID: 3627099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term anticoagulant treatment in patients with total valvular prosthesis. Personal contribution (author's transl)].
    Cerri B; Bianchi G; Zampaglione G; Grasso S; Pesciatini F
    G Ital Cardiol; 1974; 4(6):687-92. PubMed ID: 4448341
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty-two years without anticoagulation with metallic heart valve.
    Yildiz A; Ozcan F; Dogan M; Ozlü MF; Sasmaz A
    J Natl Med Assoc; 2006 Aug; 98(8):1348-9. PubMed ID: 16916135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation and long-term anticoagulation after heart valve replacements.
    Thulin LI; Olin CL
    Arq Bras Cardiol; 1987 Nov; 49(5):265-8. PubMed ID: 3454148
    [No Abstract]   [Full Text] [Related]  

  • 20. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.